Sicheng Li Selected Research

Sicheng Li Research Topics

Disease

5	Ischemic Stroke 06/2022 - 01/2020
4	Stroke (Strokes) 01/2021 - 01/2020
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2018 - 08/2017
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2022 - 12/2020
3	Inflammation (Inflammations) 01/2021 - 01/2020
2	Body Weight (Weight, Body) 01/2022 - 01/2021
2	Wounds and Injuries (Trauma) 12/2021 - 01/2021
2	Brain Injuries (Brain Injury) 01/2021 - 01/2020
2	Ischemia 12/2020 - 01/2020
2	Neoplasms (Cancer) 09/2019 - 11/2018
2	Weight Loss (Weight Reduction) 11/2018 - 04/2018
1	Chronic Renal Insufficiency 09/2022
1	Brain Infarction 06/2022
1	Neuroinflammatory Diseases 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Bites and Stings (Sting) 12/2020
1	Hyperplasia 08/2019
1	Adenoma (Adenomas) 08/2019
1	Hyperaldosteronism (Conn Syndrome) 08/2019
1	Sepsis (Septicemia) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2018
1	Polyuria 11/2018
1	Polydipsia 11/2018
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2018
1	Hyperglycemia 11/2018
1	Autoimmune Diseases (Autoimmune Disease) 09/2018
1	Low Back Pain (Lumbago) 04/2018
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2018
1	Pancreatitis 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Uremia 12/2015
1	Obesity 09/2014

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 11/2018 - 09/2014
2	Therapeutic UsesIBA 12/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2018
2	LigandsIBA 12/2020 - 05/2018
2	Insulin (Novolin)FDA Link 09/2018 - 08/2017
2	Messenger RNA (mRNA)IBA 12/2015 - 09/2014
1	Air Pollutants (Pollutants, Air)IBA 09/2022
1	Neuroprotective AgentsIBA 06/2022
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 06/2022
1	salvinorin AIBA 06/2022
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 06/2022
1	Interleukin-33IBA 01/2022
1	HydrogelsIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AlbuminsIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	QiDiTangShen granulesIBA 01/2021
1	OsteopontinIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 12/2020
1	Biological ProductsIBA 12/2020
1	salicylhydroxamic acid (SHAM)IBA 12/2020
1	MAP kinase kinase kinase 7IBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	AldosteroneIBA 08/2019
1	NAD (NADH)IBA 01/2019
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 11/2018
1	pembrolizumabIBA 11/2018
1	B7-H1 AntigenIBA 11/2018
1	KetonesIBA 11/2018
1	Immune Checkpoint InhibitorsIBA 11/2018
1	C-PeptideIBA 11/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2018
1	Angiopoietin-Like Protein 8IBA 01/2018
1	NivolumabIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Chemotactic FactorsIBA 12/2015
1	Toll-Like Receptor 4IBA 09/2014

Therapy/Procedure

2	Therapeutics 01/2020 - 11/2018
1	Intranasal Administration 06/2022
1	Immunomodulation 06/2022
1	Injections 12/2021
1	Drug Therapy (Chemotherapy) 09/2019